Evidence map›Paper›PMID 39508297›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2024

Viscoelastic High-Molecular-Weight Hyaluronic Acid Hydrogels Support Rapid Glioblastoma Cell Invasion with Leader-Follower Dynamics.

Emily M Carvalho, Erika A Ding, Atul Saha, Diana Cruz Garcia, Anna Weldy, Peter-James H Zushin, Andreas Stahl, Manish K Aghi, Sanjay Kumar

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Emily M CarvalhoDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.ORCID 0000-0002-9438-8514
Erika A DingDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.
Atul SahaDepartment of Neurosurgery, University of California, San Francisco, CA, 94158, USA.
Diana Cruz GarciaDepartment of Bioengineering, University of California, Berkeley, CA, 94720, USA.
Anna WeldyDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.
Peter-James H ZushinDepartment of Nutritional Sciences and Toxicology, University of California, Berkeley, 94720, USA.
Andreas StahlDepartment of Nutritional Sciences and Toxicology, University of California, Berkeley, 94720, USA.
Manish K AghiDepartment of Neurosurgery, University of California, San Francisco, CA, 94158, USA.
Sanjay KumarDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.ORCID 0000-0002-9996-4883

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo, FREDERICK F LANG · 2008 to 2026
$41.2M
Biophysical Control of Cell Form and Function by Single Actomyosin Stress Fibers: Instrument SupplementR01GM122375 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI KUMAR, SANJAY · 2017 to 2025
$2.7M
Cellular mechanobiology and engineering of active brown adipose tissueR01DK118940 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI KUMAR, SANJAY, STAHL, ANDREAS · 2019 to 2022
$2.3M
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for GlioblastomaR01CA247970 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LANG, FREDERICK F · 2020 to 2024
$2.2M
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systemsR01CA227136 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGHI, MANISH · 2018 to 2022
$2.2M
Retroviral RLI immunomodulatory gene therapy for glioblastomaR01NS123808 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Manish Aghi · 2022 to 2026
$2.1M
Role of Biomechanical Interfaces Created by Focal Adhesion Kinase in Catecholamine SignalingR01DK141135 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI Sanjay Kumar, Andreas Stahl · 2024 to 2026
$2.0M
MSC-Derived Exosomes and MicroRNA in Glioma TherapyR01CA214749 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LANG, FREDERICK F · 2018 to 2022
$1.8M
Mechanisms of adhesion and invasion in hyaluronic acid matricesR01CA260443 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI KUMAR, SANJAY · 2021 to 2025
$1.8M
National Science FoundationNCI NIH HHS 1R01CA214749NCI NIH HHS 1R01CA247970NCI NIH HHS 2P50CA127001NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672NCI NIH HHS P50 CA127001NCI NIH HHS R01 CA214749NCI NIH HHS R01 CA227136NCI NIH HHS R01 CA247970NCI NIH HHS R01 CA260443NIDDK NIH HHS R01 DK118940NIDDK NIH HHS R01 DK141135NIGMS NIH HHS R01 GM122375NIH HHS R01118940NIH HHS R01CA227136NIH HHS R01CA260443NIH HHS R01GM122375NINDS NIH HHS R01 NS123808
6 · The paper itself

Abstract

Hyaluronic acid (HA), the primary component of brain extracellular matrix, is increasingly used to model neuropathological processes, including glioblastoma (GBM) tumor invasion. While elastic hydrogels based on crosslinked low-molecular-weight (LMW) HA are widely exploited for this purpose and have proven valuable for discovery and screening, brain tissue is both viscoelastic and rich in high-MW (HMW) HA, and it remains unclear how these differences influence invasion. To address this question, hydrogels comprised of either HMW (1.5 MDa) or LMW (60 kDa) HA are introduced, characterized, and applied in GBM invasion studies. Unlike LMW HA hydrogels, HMW HA hydrogels relax stresses quickly, to a similar extent as brain tissue, and to a greater extent than many conventional HA-based scaffolds. GBM cells implanted within HMW HA hydrogels invade much more rapidly than in their LMW HA counterparts and exhibit distinct leader-follower dynamics. Leader cells adopt dendritic morphologies similar to invasive GBM cells observed in vivo. Transcriptomic, pharmacologic, and imaging studies suggest that leader cells exploit hyaluronidase, an enzyme strongly enriched in human GBMs, to prime a path for followers. This study offers new insight into how HA viscoelastic properties drive invasion and argues for the use of highly stress-relaxing materials to model GBM.

Indexed as

GlioblastomaHyaluronic AcidHydrogelsMolecular WeightNeoplasm InvasivenessAnimalsBrain NeoplasmsCell Line, TumorElasticityHumansHyaluronoglucosaminidaseMiceViscosityHyaluronic AcidHyaluronoglucosaminidaseHydrogelsglioblastoma (GBM)high‐molecular‐weight (HMW)hyaluronic acid (HA)stress‐relaxingviscoelastic

Identifiers

PMID39508297
PMCPMC11637900

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.